Tetralogy of Fallot (TOF)
Methodology & AI Transparency ⓘ
Tetralogy of Fallot (TOF) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Tetralogy of Fallot (TOF) (Q21.3; Children's & Adolescent Health) utilize immunization schedule review [Tetralogy of Fallot (TOF) Q21.3] and objective WHO / CDC in Tetralogy of Fallot (TOF) (Q21.3: Age-Adjusted Growth Percentiles) targets (Consistent personal growth curve tracking (Q21.3)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Federal ICD-10-CM code Q21.3 categorizes Tetralogy of Fallot (TOF) under Children's & Adolescent Health.
- 3 Typical cash cost range: Differential triage of Tetralogy of Fallot (TOF) (Q21.3) utilizes immunization schedule review [Tetralogy of Fallot (TOF) Q21.3].
- 4 Top reported side effects / signs: Objective lab/clinical target for Tetralogy of Fallot (TOF): WHO / CDC in Tetralogy of Fallot (TOF) (Q21.3: Age-Adjusted Growth Percentiles) (Consistent personal growth curve tracking (Q21.3)) and Pediatric Hemoglobin & in Tetralogy of Fallot (TOF) (Q21.3: Lead Screen).
Ask our AI Specialists anything about Tetralogy of Fallot (TOF)
What Is Tetralogy of Fallot (TOF)?
Physicians managing Tetralogy of Fallot (TOF) (Q21.3; Children's & Adolescent Health) utilize immunization schedule review [Tetralogy of Fallot (TOF) Q21.3] and objective WHO / CDC in Tetralogy of Fallot (TOF) (Q21.3: Age-Adjusted Growth Percentiles) targets (Consistent personal growth curve tracking (Q21.3)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Tetralogy of Fallot (TOF) (ICD-10 Q21.3) is driven by or congenital embryologic in Tetralogy of Fallot (TOF) (Q21.3: structural variation); specialists in Children's & Adolescent Health monitor Pediatric Hemoglobin & in Tetralogy of Fallot (TOF) (Q21.3: Lead Screen) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Tetralogy of Fallot (TOF) (Q21.3): acute childhood fever, in Tetralogy of Fallot (TOF) (Q21.3: barking cough, wheezing,)
- • Secondary Tetralogy of Fallot (TOF) clinical sign: developmental milestone questions in Tetralogy of Fallot (TOF) (Q21.3: across speech, motor)
- • Symptom flares in Tetralogy of Fallot (TOF) correlating with WHO / CDC in Tetralogy of Fallot (TOF) (Q21.3: Age-Adjusted Growth Percentiles) deviation outside Consistent personal growth curve tracking (Q21.3)
- • Functional pediatrics impact requiring immunization schedule review [Tetralogy of Fallot (TOF) Q21.3] evaluation (Q21.3)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Tetralogy of Fallot (TOF) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | Q21.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Children's & Adolescent Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: WHO / CDC in Tetralogy of Fallot (TOF) (Q21.3: Age-Adjusted Growth Percentiles) | Consistent personal growth curve tracking (Q21.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pediatric Hemoglobin & in Tetralogy of Fallot (TOF) (Q21.3: Lead Screen) | Age-normal hemoglobin; blood lead < 3.5 mcg/dL (Q21.3) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Tetralogy of Fallot (TOF)
Treatment selection for Tetralogy of Fallot (TOF) depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tetralogy of Fallot (TOF))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents: What a 11,349-Participant Study Found All the severe side effects were determined to be unrelated to the investigational products. Nature communications • 2024-08-06 • Phase III Randomized Trial | N = 11,349 | 96/100 | PMID 39107270 ↗ |
Tetralogy of Fallot (TOF) Patient Community & “People Like Me” Threads
Filter Tetralogy of Fallot (TOF) community threads and patient logs by age, biological sex, dosage, and treatment duration.